A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)

NCT02861534 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

5050

Enrollment

INDUSTRY

Sponsor class

Conditions

Heart Failure
Chronic Heart Failure With Reduced Ejection Fraction

Interventions

DRUG: Vericiguat
DRUG: Placebo for vericiguat

Sponsor

Merck Sharp & Dohme LLC

Collaborators

[object Object]
[object Object]
[object Object]